#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, July 26 '25)

 

Biochem Biophys Res Commun

1. KUSUMOTO T, Yotsukura M, Asakura T, Namkoong H, et al
   Induced lung epithelial-like cells derived by direct reprogramming rescue influenza virus-induced lung injury in mice.
   Biochem Biophys Res Commun. 2025;778:152384.
   PubMed         Abstract available
   
   

   
   J Infect

2. SAITO R, Chon I, Sato I, Kawashima T, et al
   Impact of polymerase acidic subunit (PA) substitutions on fever and symptoms in pediatric influenza A patients treated with baloxavir: A pooled four-season analysis.
   J Infect. 2025;91:106555.
   PubMed         Abstract available
   
   

   
   J Infect Dis

3. SIMOES EAF, Suss RJ, Raje DV
   Human Metapneumovirus, Respiratory Syncytial Virus and Influenza Associated Pneumonia Hospitalizations in Colorado Adults Aged Over 50 Years: 2016-2023.
   J Infect Dis. 2025 Jul 21:jiaf381. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

4. MANNSVERK S, Villamil Giraldo AM, Kasson PM
   Influenza viral infection at the plasma membrane is restricted by lipid composition.
   J Virol. 2025 Jul 24:e0110525. doi: 10.1128/jvi.01105.
   PubMed         Abstract available
   
   
5. SIMONICH CAL, McMahon TE, Ju X, Yu TC, et al
   RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.
   J Virol. 2025;99:e0053125.
   PubMed         Abstract available
   
   
6. ZHANG J, Li M, Cheng J, Wang Y, et al
   CypA inhibits respiratory syncytial virus (RSV) replication by suppressing glycolysis through the downregulation of PKM2 expression.
   J Virol. 2025;99:e0007425.
   PubMed         Abstract available
   
   
7. POWELL BH, Witwer KW, Meffert MK
   Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression.
   J Virol. 2025 Jun 18:e0091425. doi: 10.1128/jvi.00914.
   PubMed         Abstract available
   
   
8. CHEN Y, Shi Y, Zuo X, Dong X, et al
   UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation.
   J Virol. 2025 Jun 18:e0074125. doi: 10.1128/jvi.00741.
   PubMed         Abstract available
   
   
9. HARRIS C, Kapingidza AB, San JE, Christopher J, et al
   Design of SARS-CoV-2 RBD immunogens to focus immune responses toward conserved coronavirus epitopes.
   J Virol. 2025 Jun 13:e0046525. doi: 10.1128/jvi.00465.
   PubMed         Abstract available
   
   
10. LOKUGAMAGE KG, Zhou Y, Alvarado RE, Plante JA, et al
    Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection.
    J Virol. 2025 Jun 12:e0209124. doi: 10.1128/jvi.02091.
    PubMed         Abstract available
    
    
11. COTTIGNIES-CALAMARTE A, Marteau F, He F, Belouzard S, et al
    Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response.
    J Virol. 2025 Jun 12:e0039425. doi: 10.1128/jvi.00394.
    PubMed         Abstract available
    
    
12. MORGAN AL, Vu MN, Zhou Y, Lokugamage KG, et al
    The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2.
    J Virol. 2025 Jun 10:e0046725. doi: 10.1128/jvi.00467.
    PubMed         Abstract available
    
    
13. FOSTER CSP, Walker GJ, Jean T, Wong M, et al
    Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution.
    J Virol. 2025 Jun 9:e0036325. doi: 10.1128/jvi.00363.
    PubMed         Abstract available
    
    
14. NGUYEN D, Laidlaw SM, Dong X, Wand M, et al
    SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
    J Virol. 2025 Jun 4:e0051925. doi: 10.1128/jvi.00519.
    PubMed         Abstract available
    
    
15. KALIN JH, Yin Y, Tran MT, Piassek M, et al
    Discovery of a non-nucleoside inhibitor that binds to a novel site in the palm domain of the respiratory syncytial virus RNA-dependent RNA polymerase.
    J Virol. 2025;99:e0017825.
    PubMed         Abstract available
    
    

    
    Lancet

16. 
    Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

17. GONG R, Feng Z, Zhang Y
    Using homologous network to identify reassortment risk in H5Nx avian influenza viruses.
    PLoS Comput Biol. 2025;21:e1013301.
    PubMed         Abstract available
    
    
18. KEITHLEY J, Choudhuri A, Adhikari B, Pemmaraju SV, et al
    Analyzing greedy vaccine allocation algorithms for metapopulation disease models.
    PLoS Comput Biol. 2025;21:e1012539.
    PubMed         Abstract available
    
    
19. KOLAR MR, Kobzarenko V, Mitra D
    Efficient discovery of frequently co-occurring mutations in a sequence database with matrix factorization.
    PLoS Comput Biol. 2025;21:e1012391.
    PubMed         Abstract available
    
    

    
    PLoS Med

20. KNOWLTON KU, Siegel LK, Barkauskas CE, Bhagani S, et al
    Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.
    PLoS Med. 2025;22:e1004616.
    PubMed         Abstract available
    
    

    
    PLoS One

21. MONROY-IGLESIAS MJ, Thavarajah R, Beckmann K, Josephs DH, et al
    Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobank.
    PLoS One. 2025;20:e0328232.
    PubMed         Abstract available
    
    
22. BISHOP F, Howick J, Vennik J, Bostock J, et al
    Feasibility trial of a new digital training package to enhance primary care practitioners' communication of clinical empathy and realistic optimism.
    PLoS One. 2025;20:e0324649.
    PubMed         Abstract available
    
    
23. KANG ZT, Yen PT, Cheong SA
    Indicator from the graph Laplacian of stock market time series cross-sections can precisely determine the durations of market crashes.
    PLoS One. 2025;20:e0327391.
    PubMed         Abstract available
    
    
24. WILLIAMS R, Bolton T, Jenkins D, Mizani MA, et al
    The challenges of replication: A worked example of methods reproducibility using electronic health record data.
    PLoS One. 2025;20:e0326335.
    PubMed         Abstract available
    
    
25. DORNEY J, Ebna Mannan I, Malicki C, Wisk LE, et al
    Impact of SARS-CoV-2 on healthcare and essential workers: A longitudinal study of PROMIS-29 outcomes.
    PLoS One. 2025;20:e0324755.
    PubMed         Abstract available
    
    
26. ROMAN-MONTES CM, Tamez-Torres KM, Guaracha-Basanez GA, Ordinola-Navarro A, et al
    Factors associated with indeterminate QuantiFERON-TB Gold Plus Test results during the COVID-19 pandemic.
    PLoS One. 2025;20:e0326615.
    PubMed         Abstract available
    
    
27. THITY NT, Rahman A, Dulmini A, Yasmin MN, et al
    An illustration of multi-class roc analysis for predicting internet addiction among university students.
    PLoS One. 2025;20:e0325855.
    PubMed         Abstract available
    
    
28. MA KPK, Stober T, Gottlieb M, Geyer RE, et al
    Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study.
    PLoS One. 2025;20:e0325948.
    PubMed         Abstract available
    
    
29. KRAPEZ U, Kuhar U, Senica P, Slavec B, et al
    Different SARS-CoV-2 variants inhibited by RRM designed peptide.
    PLoS One. 2025;20:e0327582.
    PubMed         Abstract available
    
    
30. QI J, Huang D, Chen Y, Huang D, et al
    From the frontlines to the future: Anti-epidemic volunteer experience and career rewards for doctors.
    PLoS One. 2025;20:e0328044.
    PubMed         Abstract available
    
    
31. POLLETT SD, Colombo RE, Richard SA, Lalani T, et al
    The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics.
    PLoS One. 2025;20:e0317065.
    PubMed         Abstract available
    
    
32. GOTTLIEB M, Spatz ES, Yu H, Ebna Mannan I, et al
    Effects of long COVID on healthcare utilization.
    PLoS One. 2025;20:e0327218.
    PubMed         Abstract available
    
    
33. DARAGHMEH DN, Salah A, Hamdan N, Zamareh A, et al
    Attitudes, beliefs, and practices regarding complementary and alternative medicine use: Influenza vaccine intake.
    PLoS One. 2025;20:e0320412.
    PubMed         Abstract available
    
    
34. ROBERTI J, Carmiol-Rodriguez P, Chan-Liang E, Aguilar-Vidrio OA, et al
    Enhancing tuberculosis treatment support: A thematic analysis of interactive messages in a digital adherence technology trial to identify needs, challenges, and strategies for improvement.
    PLoS One. 2025;20:e0326492.
    PubMed         Abstract available
    
    
35. TAVARES IC, Maria Guerreiro da Silva D, Ferreira Monteiro W, Janara Veras Lima K, et al
    Therapeutic itineraries and testimonies of COVID-19 patients in Manaus, the epicenter of the pandemic in the Brazilian Amazon.
    PLoS One. 2025;20:e0327127.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. MENON T, McQuilten HA, Samir J, Nguyen THO, et al
    Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan.
    Proc Natl Acad Sci U S A. 2025;122:e2501167122.
    PubMed         Abstract available
    
    
37. LEE AS
    Stress-induced translocation of the endoplasmic reticulum chaperone GRP78/BiP and its impact on human disease and therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2412246122.
    PubMed         Abstract available
    
    

    
    Vaccine

38. PICKERING H, Valli E, Carlock MA, Cappelletti M, et al
    Influenza strain-specific T cell responses longitudinally post-vaccination with FluZone.
    Vaccine. 2025;62:127506.
    PubMed         Abstract available
    
    

    
    Virus Res

39. SANZ-MUNOZ I, Martin-Toribio A, Garcia-Concejo A, Arroyo-Hernantes I, et al
    A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain.
    Virus Res. 2025;358:199599.
    PubMed         Abstract available
    
    
40. CHEN Z, Cai M, Chai L, Li X, et al
    Anti-influenza Activity of Blumea Balsamifera (L.) DC. Extract: In Vitro and In Vivo Evaluation Against Multiple Influenza Virus Strains.
    Virus Res. 2025 Jul 20:199606. doi: 10.1016/j.virusres.2025.199606.
    PubMed         Abstract available